Article Versions Notes

Paketci S, Williams J, Pisciotta W, Loye R, Waller AV, Haque R, Brealey D, Singer M, Whittle J, Moonesinghe R, et al. Peri-Operative Antimicrobial Prophylaxis Modulates CD4⁺ Lymphocyte Immunophenotype Ex Vivo in High-Risk Patients Undergoing Major Elective Surgery—A Preliminary Observational Study. Antibiotics. 2025; 14(10):1026. https://doi.org/10.3390/antibiotics14101026

Paketci, Susi, Jack Williams, Walter Pisciotta, Richard Loye, Alessia V. Waller, Rahila Haque, David Brealey, Mervyn Singer, John Whittle, Ramani Moonesinghe, and et al. 2025. "Peri-Operative Antimicrobial Prophylaxis Modulates CD4⁺ Lymphocyte Immunophenotype Ex Vivo in High-Risk Patients Undergoing Major Elective Surgery—A Preliminary Observational Study" Antibiotics 14, no. 10: 1026. https://doi.org/10.3390/antibiotics14101026

Paketci, S., Williams, J., Pisciotta, W., Loye, R., Waller, A. V., Haque, R., Brealey, D., Singer, M., Whittle, J., Moonesinghe, R., Arulkumaran, N., Snow, T. A. C., & the University College London Hospitals Critical Care Research Team. (2025). Peri-Operative Antimicrobial Prophylaxis Modulates CD4⁺ Lymphocyte Immunophenotype Ex Vivo in High-Risk Patients Undergoing Major Elective Surgery—A Preliminary Observational Study. Antibiotics, 14(10), 1026. https://doi.org/10.3390/antibiotics14101026